ORIC PHARMACEUTICALS, INC.: current accounts payable
Current accounts payable for ORIC PHARMACEUTICALS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ORIC PHARMACEUTICALS, INC. financial histories
What this measure means
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
Exact concept: us-gaap:AccountsPayableCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 3,824,000 | USD | 2026-02-23 | 10-K · 0001193125-26-064005 |
| At date | 2024-12-31 | 1,548,000 | USD | 2026-02-23 | 10-K · 0001193125-26-064005 |
| At date | 2023-12-31 | 944,000 | USD | 2025-02-18 | 10-K · 0000950170-25-022273 |
| At date | 2022-12-31 | 1,320,000 | USD | 2024-03-11 | 10-K · 0000950170-24-029298 |
| At date | 2021-12-31 | 1,886,000 | USD | 2023-03-16 | 10-K · 0000950170-23-008483 |
| At date | 2020-12-31 | 757,000 | USD | 2022-03-21 | 10-K · 0000950170-22-004239 |
| At date | 2019-12-31 | 152,000 | USD | 2021-03-23 | 10-K · 0001564590-21-014865 |
Related financial histories
- ORIC PHARMACEUTICALS, INC.: total assets
- ORIC PHARMACEUTICALS, INC.: total liabilities
- ORIC PHARMACEUTICALS, INC.: stockholders equity
- ORIC PHARMACEUTICALS, INC.: cash and cash equivalents
- ORIC PHARMACEUTICALS, INC.: net income or loss
- ORIC PHARMACEUTICALS, INC.: operating cash flow
- ORIC PHARMACEUTICALS, INC.: capital expenditure payments
- ORIC PHARMACEUTICALS, INC.: financing cash flow
- ORIC PHARMACEUTICALS, INC.: investing cash flow
- ORIC PHARMACEUTICALS, INC.: retained earnings or deficit
- ORIC PHARMACEUTICALS, INC.: basic weighted-average shares
- ORIC PHARMACEUTICALS, INC.: diluted weighted-average shares
- ORIC PHARMACEUTICALS, INC.: basic earnings per share
- ORIC PHARMACEUTICALS, INC.: diluted earnings per share
- ORIC PHARMACEUTICALS, INC.: net property, plant and equipment
- ORIC PHARMACEUTICALS, INC.: share-based compensation expense
- ORIC PHARMACEUTICALS, INC.: operating income or loss
- ORIC PHARMACEUTICALS, INC.: current assets
- ORIC PHARMACEUTICALS, INC.: current liabilities
- ORIC PHARMACEUTICALS, INC.: operating expenses
Inspect the source
- Entity
- ORIC PHARMACEUTICALS, INC. / CIK 0001796280
- Captured
- 2026-09-21T17:27:48.811Z
- SEC response SHA-256
c871f4ae99434ca4e77917ac2fb9c7474f96a5b445a13c046620f15c44d1f0e6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001796280.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))